Suppr超能文献

人类、猿猴和猫免疫缺陷病毒的主要核心蛋白p24部分表达于病毒感染细胞的表面。

Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells.

作者信息

Nishino Y, Ohki K, Kimura T, Morikawa S, Mikami T, Ikuta K

机构信息

Section of Serology, Hokkaido University, Sapporo, Japan.

出版信息

Vaccine. 1992;10(10):677-83. doi: 10.1016/0264-410x(92)90089-3.

Abstract

We have previously shown the expression of human immunodeficiency virus type 1 (HIV-1) major gag protein, p24, on the surface of persistently HIV-1-infected cells by using murine monoclonal antibodies (mAb). We now report that the cell surface gag p24 antigen expression is a universal phenomenon among HIV-1, simian immunodeficiency virus (SIV), and feline immunodeficiency virus (FIV). The mAbs prepared by immunization with purified HIV-1 particles were used as antibodies cross-reactive to HIV-1 and SIVagmp24 antigens. The mAbs to FIV p24 were raised against the gag precursor 50 kDa protein of FIV, which was expressed by Baculovirus vector. The p24 antigen expression on the cell surface was detectable in certain combinations of virus-host cell systems in all of these viruses. Since these p24 regions of the animal viruses seem to play as important a role in cell-mediated immunity as that of HIV-1, the p24 applicability as a candidate epitope for vaccine development could be evaluated in those animals.

摘要

我们之前通过使用鼠单克隆抗体(mAb)证明了1型人类免疫缺陷病毒(HIV-1)主要gag蛋白p24在持续感染HIV-1的细胞表面的表达。我们现在报告,细胞表面gag p24抗原表达在HIV-1、猴免疫缺陷病毒(SIV)和猫免疫缺陷病毒(FIV)中是一种普遍现象。用纯化的HIV-1颗粒免疫制备的mAb被用作与HIV-1和SIVagmp24抗原交叉反应的抗体。针对FIV p24的mAb是针对由杆状病毒载体表达的FIV gag前体50 kDa蛋白产生的。在所有这些病毒的某些病毒-宿主细胞系统组合中,细胞表面的p24抗原表达是可检测到的。由于动物病毒的这些p24区域在细胞介导的免疫中似乎与HIV-1的p24区域发挥着同样重要的作用,因此可以在那些动物中评估p24作为疫苗开发候选表位的适用性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验